| Biomarker ID | 1072 |
| PMID | 23417432 |
| Year | 2013 |
| Biomarker | Inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in Prostate Cancer |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Platelet degranulation Homo sapiens R-HSA-114608, Response to elevated platelet cytosolic Ca2+ Homo sapiens R-HSA-76005, Platelet activation, signaling and aggregation Homo sapiens R-HSA-76002, Hemostasis Homo sapiens R-HSA-109582 |
| Experiment | Prostate Cancer Vs Controls |
| Type of Biomarker | Diagnostic |
| Cohort | 15 controls, 20 patients with Benign prostatic Hyperplaisa were chosen for the study, |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.006 |
| Method Used | 2D-gel Electrophoresis |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |